BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help

Search Results

Documents 1-25 out of 43 found
  Current Search:  amoxicillin: 43     

HTML
100%
Another biotech CEO to leave
Rudnic departs as head of MiddleBrook as part of a $100M cash infusion \ Featured Jobs For the second time in two weeks, a giant of Marylands biotech industry has announced plans to step down.

More News Last week it was CEO David M.

Mott...

Gazette.net:  Jul 4 2008 3:25AM
Matching: amoxicillin
Find similar documents
HTML
100%
With $100 Million Influx, MiddleBrook CEO Is Out
Edward M.

Rudnic, MiddleBrook Pharmaceuticals's chief executive, plans to leave the company he founded in exchange for an outside investment of $100 million.

MiddleBrook has been openly searching for a buyer over the past year.

In the...

Washington Post:  Jul 3 2008 2:49AM
Matching: amoxicillin
Find similar documents
HTML
100%
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM)
Strategic Review Results in $100MM Investment by Equity Group Investments;Experienced Commercial Executive Management Team Appointed;Preparing for Potential MOXATAG Launch in the First Half of 2009 GERMANTOWN, Md., July 1 /PRNewswire...
TickerTech.com:  Jul 2 2008 12:01PM
Matching: amoxicillin
Find similar documents
HTML
100%
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM)
GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.

(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...

Twin Cities Business Journal:  Jul 2 2008 4:30AM
Matching: amoxicillin
Find similar documents
HTML
100%
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM)
GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.

(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...

NewsBlaze:  Jul 2 2008 3:50AM
Matching: amoxicillin
Find similar documents
HTML
100%
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM)
GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.

(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...

Atlanta Business Chronicle:  Jul 2 2008 3:33AM
Matching: amoxicillin
Find similar documents
HTML
100%
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM)
GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.

(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...

San Francisco Business Times:  Jul 2 2008 3:30AM
Matching: amoxicillin
Find similar documents
HTML
100%
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM)
GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.

(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...

Portland Business Journal:  Jul 2 2008 3:25AM
Matching: amoxicillin
Find similar documents
HTML
100%
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM)
GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.

(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...

Cincinnati Business Journal:  Jul 2 2008 3:25AM
Matching: amoxicillin
Find similar documents
HTML
100%
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM)
GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.

(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...

Business Journal of Milwaukee:  Jul 2 2008 3:20AM
Matching: amoxicillin
Find similar documents
HTML
100%
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM)
GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.

(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...

Nashville Business Journal:  Jul 2 2008 3:19AM
Matching: amoxicillin
Find similar documents
HTML
100%
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM)
GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.

(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...

Columbus Business First:  Jul 2 2008 3:18AM
Matching: amoxicillin
Find similar documents
HTML
100%
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM)
GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.

(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...

The Business Journal Phoenix:  Jul 2 2008 3:16AM
Matching: amoxicillin
Find similar documents
HTML
100%
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM)
GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.

(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...

San Antonio Business Journal:  Jul 2 2008 3:11AM
Matching: amoxicillin
Find similar documents
HTML
100%
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM)
GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.

(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...

Biz Journals:  Jul 2 2008 3:07AM
Matching: amoxicillin
Find similar documents
HTML
100%
Shares of MiddleBrook Pharmaceuticals Tumble On Resignation Of President, CEO
(RTTNews) - Shares of pharmaceutical company MiddleBrook Pharmaceuticals, Inc.

(MBRK | Quote | Chart | News | PowerRating) plunged Wednesday morning after the company announced the resignation of the company's President and CEO Edward...

TradingMarkets:  Jul 2 2008 3:08PM
Matching: amoxicillin
Find similar documents
HTML
100%
MiddleBrook Sinks as Buyout Hopes Fade
MiddleBrook Pharmaceuticals MBRK couldn't find a buyer.

The Germantown, Md.-based drugmaker said Wednesday that an outside investment group will pump $100 million into the company to fund the commercial launch of its recently approved...

TheStreet.com:  Jul 2 2008 3:39PM
Matching: amoxicillin
Find similar documents
HTML
100%
Middlebrook Pharma gets $100M investment
GERMANTOWN, Md.

- Drug maker MiddleBrook Pharmaceuticals Inc.

said President and Chief Executive Edward M.

Rudnic will step down under terms of Equity Group Investments LLC's $100 million investment in the company.

Shares fell $1.56,...

CNBC:  Jul 2 2008 2:42PM
Matching: amoxicillin
Find similar documents
HTML
100%
Middlebrook Pharma gets $100M investment
Drug maker MiddleBrook Pharmaceuticals Inc.

said President and Chief Executive Edward M.

Rudnic will step down under terms of Equity Group Investments LLC's $100 million investment in the company.

Shares fell $1.56, or 51 percent, to ...

Forbes.com:  Jul 2 2008 2:07PM
Matching: amoxicillin
Find similar documents
HTML
100%
Middlebrook Pharma gets $100M investment
Shares fell $1.56, or 51 percent, to $1.51 in premarket trading, having closed Tuesday's regular session at $3.07.

Middlebrook is selling 30.3 million common shares at $3.30 each to Equity Group and a five-year warrant to buy 12.1 million...

Yahoo! Canada:  Jul 2 2008 1:38PM
Matching: amoxicillin
Find similar documents
HTML
100%
Middlebrook Pharma gets $100M investment
GERMANTOWN, Md.

(AP) -- Drug maker MiddleBrook Pharmaceuticals Inc.

said President and Chief Executive Edward M.

Rudnic will step down under terms of Equity Group Investments LLC's $100 million investment in the company.

Shares fell ...

AP via Yahoo!:  Jul 2 2008 1:34PM
Matching: amoxicillin
Find similar documents
HTML
100%
MiddleBrook Pharma plunges 50% after $100M investment announcement
MiddleBrook Pharmaceuticals Inc.

(Nasdaq:MBRK) tanked 50% in pre-market trading on Wednesday after the company announced late Tuesday it had made an agreement with private investment firm Equity Group Investments for $100 million equity...

SmallCapInvestor.com:  Jul 2 2008 1:06PM
Matching: amoxicillin
Find similar documents
HTML
100%
Q&a: Disease's Cause, Cures
What is it?

Lyme disease is caused by the bacterium Borrelia burgdorferi?

How do you get it?

It is transmitted to humans by the bite of infected black-legged ticks - in our area, the deer tick - that can be carried on rodents, deer or...

Newsday:  Jul 2 2008 9:15AM
Matching: amoxicillin
Find similar documents
HTML
100%
FDA MedWatch - March 2008 Safety-Related Labeling Changes Posted
-The March 2008 posting includes 50 drug products with safety labeling changes to the following sections: BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, and PATIENT PACKAGE INSERTS, and MEDICATION ES.

The...

Pharma Live:  Jul 1 2008 5:54PM
Matching: amoxicillin
Find similar documents
HTML
100%
Evaluation and Management of the Infected Total Hip and Knee
Describe a classification system and discuss the relevant prognostic factors that aid in the management of the infected hip and knee arthroplasty.

Discuss the currently available tests that are used in the diagnosis of infected total hip...

Orthopedics Today:  Jun 25 2008 7:44PM
Matching: amoxicillin
Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.